281 related articles for article (PubMed ID: 17509867)
1. Epidural analgesia for parturients with type 1 von Willebrand disease.
Marrache D; Mercier FJ; Boyer-Neumann C; Roger-Christoph S; Benhamou D
Int J Obstet Anesth; 2007 Jul; 16(3):231-5. PubMed ID: 17509867
[TBL] [Abstract][Full Text] [Related]
2. PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.
van Vliet HH; Kappers-Klunne MC; Leebeek FW; Michiels JJ
Thromb Haemost; 2008 Sep; 100(3):462-8. PubMed ID: 18766263
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
4. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
5. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.
Gadisseur A; Berneman Z; Schroyens W; Michiels JJ
Acta Haematol; 2009; 121(2-3):128-38. PubMed ID: 19506359
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy in women with different types of von Willebrand disease.
Conti M; Mari D; Conti E; Muggiasca ML; Mannucci PM
Obstet Gynecol; 1986 Aug; 68(2):282-5. PubMed ID: 3090493
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with desmopressin before epidural anesthesia in a patient with type I von Willebrand disease].
Pérez-Barrero P; Gil L; Martínez C; Bueno AB; Casado AI; Oro J
Rev Esp Anestesiol Reanim; 2003 Dec; 50(10):526-9. PubMed ID: 14737779
[TBL] [Abstract][Full Text] [Related]
8. [Childbirth without fear in case of Von Willebrand's disease].
Cornuz J; Knecht H; Delaloye JF; Bossart H; Bachmann F
Schweiz Med Wochenschr; 1993 Jan; 123(3):76-9. PubMed ID: 8426951
[TBL] [Abstract][Full Text] [Related]
9. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
10. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
11. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
[TBL] [Abstract][Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
13. Successful surgical haemostasis in patients with von Willebrand disease with Koate DVI.
Viswabandya A; Mathews V; George B; Nair SC; Baidya S; Mammen JJ; Chandy M; Srivastava A
Haemophilia; 2008 Jul; 14(4):763-7. PubMed ID: 18445014
[TBL] [Abstract][Full Text] [Related]
14. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
Gadisseur A; van der Planken M; Schroyens W; Berneman Z; Michiels JJ
Acta Haematol; 2009; 121(2-3):145-53. PubMed ID: 19506361
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and molecular characterization of von Willebrand disease type 2N in a pregnant patient who gave birth under analgesia with remifentanil.
Dell'Edera D; Guanciali Franchi P; Lioi MB; Epifania AA; Tinelli A; Monti Condesnitt V; Brizzi A; Malvasi A
J Biol Regul Homeost Agents; 2011; 25(3):469-75. PubMed ID: 22023773
[TBL] [Abstract][Full Text] [Related]
17. Acquired Von Willebrand disease in children with a Wilms' tumor.
Jonge Poerink-Stockschlader AB; Dekker I; Risseeuw-Appel IM; Hählen K
Med Pediatr Oncol; 1996 Apr; 26(4):238-43. PubMed ID: 8600334
[TBL] [Abstract][Full Text] [Related]
18. Epidural analgesia for labor and delivery in a patient with von Willebrand's disease.
Cohen S; Daitch JS; Amar D; Goldiner PL
Reg Anesth; 1989; 14(2):95-7. PubMed ID: 2487672
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy in bleeding and surgery in von Willebrand patients treated with Fanhdi a highly purified, doubly inactivated FVIII/VWF concentrate.
Hernandez-Navarro F; Quintana M; Jimenez-Yuste V; Alvarez MT; Fernandez-Morata R
Haemophilia; 2008 Sep; 14(5):963-7. PubMed ID: 18624696
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?
Favaloro EJ; Thom J; Patterson D; Just S; Dixon T; Koutts J; Baccala M; Rowell J; Baker R
Thromb Res; 2009 Apr; 123(6):862-8. PubMed ID: 19064279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
